Skip to main content
. 2013 Mar 29;3(1):63–70. doi: 10.1159/000350397

Table 3.

Table 3. Renal biomarkers to evaluate cardiovascular outcomes in CKD patients

CysC Directly involved in the atherosclerotic process; associated with increased LV mass and its concentricity

NGAL Increased expression in atherosclerotic plaque and failing myocardium in patients with CAD and heart failure